Investors /

venBio

venBio is a life sciences investment firm focused on partnering with industry leaders to develop groundbreaking medicines and technologies. The firm emphasizes novel therapeutics for unmet medical needs, aiming to position its portfolio companies for success through strategic planning and expertise in clinical development.

venBio

venBio

1700 Owens Street, Suite 595, San Francisco, CA 94158

Portfolio

ALX Oncology

Developing therapies to block the CD47 checkpoint mechanism.

#Immuno-oncology

NorthSea Therapeutics

Developing therapies for NASH and other metabolic diseases.

#Biotechnology

Harmony Biosciences

Focused on therapies for rare neurological disorders.

#Pharmaceuticals

Checkmate Pharmaceuticals

Developing cancer immunotherapy treatments.

#Biotechnology

Artiva Biotherapeutics

Developing allogeneic NK cell therapies for cancer.

#Biotechnology

Apellis Pharmaceuticals

Pioneering targeted C3 therapies.

#Biopharmaceuticals

Show More (9)